research & development
Combining recent advances in protein modification with the latest computational biology allows Allozyne to make novel protein based therapeutics. New techniques for producing modifications greatly increases the breadth of applications of these materials in areas of unmet medical need. We believe that this approach will allow us to capture a substantial share of the market for recombinant therapeutic proteins. The annual market for these therapies currently is more than $32 billion and is expected to reach $53 billion by 2010.
